STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 64 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $87,000 | -69.7% | 29,233 | -71.8% | 0.00% | – |
| Q1 2021 | $287,000 | -0.7% | 103,752 | -12.6% | 0.00% | – |
| Q4 2020 | $289,000 | +34.4% | 118,743 | +16.1% | 0.00% | – |
| Q3 2020 | $215,000 | -44.4% | 102,247 | 0.0% | 0.00% | – |
| Q2 2020 | $387,000 | +170.6% | 102,247 | +35.9% | 0.00% | – |
| Q1 2020 | $143,000 | -9.5% | 75,231 | 0.0% | 0.00% | – |
| Q4 2019 | $158,000 | -12.2% | 75,231 | 0.0% | 0.00% | – |
| Q3 2019 | $180,000 | -23.7% | 75,231 | 0.0% | 0.00% | – |
| Q2 2019 | $236,000 | -54.1% | 75,231 | +29.7% | 0.00% | – |
| Q1 2018 | $514,000 | +52.5% | 58,000 | +25.0% | 0.00% | – |
| Q4 2017 | $337,000 | +5.0% | 46,400 | 0.0% | 0.00% | – |
| Q3 2017 | $321,000 | -3.3% | 46,400 | 0.0% | 0.00% | – |
| Q2 2017 | $332,000 | – | 46,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,612,065 | $12,497,000 | 13.66% |
| Ikarian Capital, LLC | 3,392,787 | $6,412,000 | 0.48% |
| NEA Management Company, LLC | 4,141,308 | $7,827,000 | 0.41% |
| Alambic Investment Management, L.P. | 61,764 | $117,000 | 0.28% |
| KNOTT DAVID M | 181,800 | $344,000 | 0.22% |
| 683 Capital Management, LLC | 917,942 | $1,736,000 | 0.10% |
| Hudson Bay Capital Management LP | 1,409,419 | $2,664,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 388,309 | $734,000 | 0.06% |
| &PARTNERS | 15,000 | $28,000 | 0.04% |
| Diversified Trust Co | 198,534 | $375,000 | 0.02% |